外科理念指导下的大肝癌放疗

方子燕; 黎功

doi:10.3969/j.issn.1001-5256.2014.03.005

外科理念指导下的大肝癌放疗

DOI: 10.3969/j.issn.1001-5256.2014.03.005

方子燕,
黎功

安徽医科大学武警总医院临床学院肿瘤二科

详细信息

中图分类号: R735.7
计量
- 文章访问数: 2842
- HTML全文浏览量: 17
- PDF下载量: 606
- 被引次数: 0
出版历程
- 出版日期: 2014-03-20

Radiotherapy for large hepatocellular carcinoma under the guidance of surgical principle

Fang ZiYan,
Li Gong

摘要

摘要:
近年来随着医疗技术水平的提高,肝癌的治疗疗效较前有所提高,但对于大肝癌的治疗仍是临床治疗难点。介绍了大肝癌的生物学特性,对大肝癌的手术治疗(包括肝切除术和肝移植术)、放射治疗的疗效进行了阐述。认为借鉴外科理念,放疗为不能手术的患者提供了一个新的选择。但如何量化肝功能储备的指标,如何限制健肝的体积及受照射剂量,联合其他局部治疗提高肿瘤控制率,仍是亟待解决的问题。
- 肝肿瘤 /
- 肝切除术 /
- 肝移植 /
- 放射疗法 /
- 综述
Abstract:
In recent years, with the development of medical technology, the treatment outcome of hepatocellular carcinoma ( HCC) has improved substantially. However, the treatment of large HCC is still a difficult clinical problem. The biological characteristics of large HCC, as well as the surgical treatments ( hepatectomy and liver transplantation) and radiotherapy for large HCC, are reviewed. Under the guidance of surgical principle, radiotherapy can be considered as an alternative treatment for the inoperable patients. However, how to quantify the indices of hepatic functional reserve, how to limit the volume of normal liver and its radiation dose, and how to combine radiotherapy with other local treatments to increase tumor control rate are the urgent problems to be addressed.
- liver neoplasms /
- hepatectomy /
- liver transplantation /
- radiotherapy /
- review

HTML全文

参考文献(33)

[1] JEMAL A, BRAY F, CENTER MM, et al.Global cancer statistics[J].CA Cancer J Clin, 2011, 61 (2) :69-90.

[2]BOSCH FX, RIBES J, DIAZ M, et al.Primary liver cancer:worldwide incidence and trends[J].Gastroenterology, 2004, 127 (5 Suppl 1) :s5-s16.

[3]CHEN XP.Liver resection experience for the treatment of large hepatocellular carcinoma[J].J Hepatobiliary Surg, 1994 (4) :193-195. (in Chinese) 陈孝平.肝切除治疗巨大肝癌的体会[J].肝胆外科杂志, 1994 (4) :193-195.

[4]YANG JM, KAN T, CHEN H, et al.The treatment of large liver cancer with lobe resection[J].Chin J Hepatobiliary Surg, 1999, 5 (1) :50-51. (in Chinese) 杨甲梅, 阚彤, 陈汉, 等.肝叶切除治疗特大肝癌[J].中华肝胆外科杂志, 1999, 5 (1) :50-51.

[5]RUI JA, WANG SB, CHEN SG, et al.The treatment of primary liver cancer with a series of therapy including surgery operation[J].Chin J Oncol, 2001, 23 (5) :69-71. (in Chinese) 芮静安, 王少斌, 陈曙光, 等.以手术为主的系列疗法治疗原发性大肝癌 (附191例报告) [J].中华肿瘤杂志, 2001, 23 (5) :69-71.

[6]ALVES R, ALVES D, GUZ B, et al.Advanced hepatocellular carcinoma.Review of targeted molecular drugs[J].Ann Hepatol, 2011, 10 (1) :21-27.

[7]LAU WY, HO SK, YU SC, et al.Salvage surgery following downstaging of unresectable hepatocellular carcinoma[J].Ann Surg, 2004, 240 (2) :299-305.

[8]WU MC, LI AJ.The comprehensive treatment of large hepatocellular carcinoma should be valued[J].Nat Med J China, 2006, 86 (24) :1657-1659. (in Chinese) 吴孟超, 李爱军.应重视大肝癌的综合治疗[J].中华医学杂志, 2006, 86 (24) :1657-1659.

[9] BRUIX J, Sherman M.Management of hepatocellular carcinoma[J].Hepatology, 2005, 42 (5) :1208-1236.

[10]ALBERTS SR, GORES GJ, KIM GP, et al.Treatment options for hepatobiliary and pancreatic cancer[J].Mayo Clin Proc, 2007, 82 (5) :628-637.

[11]CHEN XP, QIU FZ, WU ZD, et al.Long-term outcome of resection of large hepatocellular carcinoma[J].Br J Surg, 2006, 93 (5) :600-606.

[12]CHEN XP, WU Z, QIU F.Hepatectomy for huge primary liver cancer:report of 171 patients[J].Chin J Surg, 2000, 38 (1) :6-9.

[13]ZHOU XD, TANG ZY, MA ZC, et al.Surgery for large primary liver cancer more than 10 cm in diameter[J].J Cancer Res Clin Oncol, 2003, 129 (9) :543-548.

[14]PANDEY D, LEE KH, WAI CT, et al.Long term outcome and prognostic factors for large hepatocellular carcinoma (10 cm or more) after surgical resection[J].Ann Surg Oncol, 2007, 14 (10) :2817-2823.

[15]PAWLIK TM, POON RT, ABDALLA EK, et al.Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma[J].Arch Surg, 2005, 140 (5) :450-458.

[16]IKAI I, ARII S, KOJIRO M, et al.Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey[J].Cancer, 2004, 101 (4) :796-802.

[17]GRAZIADEI IW, SANDMUELLER H, WALDENBERGER P, et al.Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome[J].Liver Transpl, 2003, 9 (6) :557-563.

[18]KOKUDO N, MAKUUCHI M.Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan:the J-HCC guidelines[J].J Gastroenterol, 2009, 44 (19) :119-121.

[19]FERRARI FS, STELLA A, PASQUINUCCI P, et al.Treatment of small hepatocellular carcinoma:a comparison of techniques and long-term results[J].Eur J Gastroenterol Hepatol, 2006, 18 (6) :659-672.

[20]KE CQ, PENG EL.Non-surgical treatment of primary liver cancer[J].China Med Herald, 2013, 10 (4) :32-35. (in Chinese) 柯传庆, 彭思兰.原发性肝癌的非手术治疗[J].中国医药导报, 2013, 10 (14) :32-35.

[21]YE SL.Loco-regional therapy for liver cancer[J].J Clin Hepatol, 2013, 29 (1) :28-31. (in Chinese) .叶胜龙.肝癌的局部区域治疗[J].临床肝胆病杂志, 2013, 29 (1) :28-31.

[22]MOORE M, HIRTE H, SIU L, et al.Phase I study to determine the safety and pharmacokinetics of the novel Raf kinase and VEGFR inhibitor BAY 43-9006, administered for 28 days on/7 days off in patients with advanced, refractory solid tumors[J].Ann Oncol, 2005, 16 (10) :1688-1694.

[23]VILLANUEVA A, NEWELL P, CHIANG DY, et al.Genomics and signaling pathways in hepatocellular carcinoma[J].Semin liver Dis, 2007, 27 (1) :55-76.

[24]PARK W, LIM DH, PAIK SW, et al.Local radiotherapy for patients with unresectable hepatocellular carcinoma[J].Int J Radiat Oncol Biol Phys, 2005, 61 (4) :1143-1150.

[25]LUO Z, RAO J, YIN WB.The status and current situation of radiotherapy in primary hepatocellular carcinoma[J].Chin J Radiat Oncol, 2006, 15 (4) :345-346. (in Chinese) 罗政, 饶建, 殷蔚伯.放疗在原发性肝癌治疗中地位和现状[J].中华放射肿瘤学杂志, 2006, 15 (4) :345-346.

[26]BAI CM.Oncology principles and practice (9th edition) [J].Med J Peking Union Med Coll Hosp, 2012, 3 (3) :357. (in Chinese) 白春梅.癌:肿瘤学原理和实践 (第9版) [J].协和医学杂志, 2012, 3 (3) :357.

[27]MORNEX F, GIRARD N, BEZIAT C, et al.Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma noneligible for curative therapies—mature results of the French Phase II RTF-1 trial[J].Int J Radiat Oncol Biol Phys, 2006, 66 (4) :1152-1158.

[28]LIU MT, LI SH, CHU TC, et al.Three-dimensional Conformal Radiation Therapy for Unresectable Hepatocellular Carcinoma Patients who had Failed with or were Unsuited for Transcatheter Arterial Chemoembolization[J].Jpn J Clin Oncol, 2004, 34 (9) :532-539.

[29]WU DH, LIU L, CHEN LH.Therapeutic effects and prognostic factors in three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma[J].World J Gastroenterol, 2004, 10 (15) :2184-2189.

[30]LIANG SX, JIANG GL, ZHU XD, et al.Prognosis factor analysis of three-dimensional conformal radiotherapy in primary liver cancer[J].Chin J Oncol, 2005, 27 (10) :613-615. (in Chinese) 梁世雄, 蒋国梁, 朱小东, 等.原发性肝癌大分割三维适形放疗的预后因素分析[J].中华肿瘤杂志, 2005, 27 (10) :613-615.

[31]JANG JW, KAY CS, YOU CR, et al.Simultaneous multitarget irradiation using helical tomotherapy for advanced hepatocellular carcinoma with multiple extrahepatic metastases[J].Int J Radiat Oncol Biol Phys, 2009, 74 (2) :412-418.

[32]KANG MK, KIM MS, KIM SK, et al.High-dose radiotherapy with intensity-modulated radiation therapy for advanced hepatocellular carcinoma[J].Tumori, 2011, 97 (6) :724-731.

[33]MENG MB, CUI YL, LU Y, et al.Transcatheter arterial chemoembolization in combination with radiotherapy for unresectable hepatocellular carcinoma:A systematic review and meta-analysis[J].Radiother Oncol, 2009, 92 (2) :184-194.

施引文献

资源附件(0)

访问统计